Dr Bradley Monk Discusses PARP Inhibitor Reimbursement
December 18th 2020, 6:30pm
VideoBradley Monk, MD, FACOG, FACS, clinician at Arizona Oncology, professor at the University of Arizona and Creighton University in Phoenix, discusses the reimbursement of PARP inhibitors in ovarian cancer.